Dianox (Decision/Risk Analysis) Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Out of Business

  • Employees
  • 12

Employees

  • Latest Deal Type
  • Out of Business

Dianox (Decision/Risk Analysis) General Information

Description

Developer of a computational aptamer discovery platform designed for the identification of undruggable proteins. The company's aptamer database and a proprietary deep learning model enable them to generate novel aptamers for efficient delivery to previously undruggable proteins, which can be used to design drugs for oncology and neurology, enabling healthcare providers to understand vitamin and hormone deficiencies that can lead to chronic diseases.

Contact Information

Website
www.dianox.com
Formerly Known As
Dianox Solutions ApS, Dianox Devices ApS, Dianox Biotechnology ApS, Dianox Medical ApS, Dianox Lab ApS
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • Care of Symbion, Fruebjergvej 3
  • 2100 Copenhagen
  • Denmark
+45 71
Primary Industry
Decision/Risk Analysis
Other Industries
Diagnostic Equipment
Vertical(s)
Artificial Intelligence & Machine Learning, HealthTech, Life Sciences, Oncology
Corporate Office
  • Care of Symbion, Fruebjergvej 3
  • 2100 Copenhagen
  • Denmark
+45 71

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Dianox (Decision/Risk Analysis) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Out of Business 10-Apr-2025 Completed Out of Business
5. Early Stage VC Completed Pre-Clinical Trials
4. Early Stage VC 18-May-2021 Completed Pre-Clinical Trials
3. Seed Round 01-Feb-2020 Completed Startup
2. Grant Completed Startup
1. Grant Completed Startup
To view Dianox (Decision/Risk Analysis)’s complete valuation and funding history, request access »

Dianox (Decision/Risk Analysis) Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary
Ordinary
To view Dianox (Decision/Risk Analysis)’s complete cap table history, request access »

Dianox (Decision/Risk Analysis) Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a computational aptamer discovery platform designed for the identification of undruggable proteins. The com
Decision/Risk Analysis
Copenhagen, Denmark
12 As of 2025

Emeryville, CA
 

South San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Dianox (Decision/Risk Analysis) Competitors (3)

One of Dianox (Decision/Risk Analysis)’s 3 competitors is Totus Medicines, a Venture Capital-Backed company based in Emeryville, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Totus Medicines Venture Capital-Backed Emeryville, CA
insitro Venture Capital-Backed South San Francisco, CA
Numerion Labs Venture Capital-Backed San Francisco, CA
You’re viewing 3 of 3 competitors. Get the full list »

Dianox (Decision/Risk Analysis) Patents

  • 2

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • Pending

  • Expiring in next 12 mo

Dianox (Decision/Risk Analysis) Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4272766-A1 Diagnostic chewing gum for chronic diseases Inactive 03-May-2022
EP-4227683-A1 Broad screening of metabolites Inactive 09-Feb-2022

Dianox (Decision/Risk Analysis) Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial

Dianox (Decision/Risk Analysis) FAQs

  • When was Dianox (Decision/Risk Analysis) founded?

    Dianox (Decision/Risk Analysis) was founded in 2019.

  • Where is Dianox (Decision/Risk Analysis) headquartered?

    Dianox (Decision/Risk Analysis) is headquartered in Copenhagen, Denmark.

  • What is the size of Dianox (Decision/Risk Analysis)?

    Dianox (Decision/Risk Analysis) has 12 total employees.

  • What industry is Dianox (Decision/Risk Analysis) in?

    Dianox (Decision/Risk Analysis)’s primary industry is Decision/Risk Analysis.

  • Is Dianox (Decision/Risk Analysis) a private or public company?

    Dianox (Decision/Risk Analysis) is a Private company.

  • What is Dianox (Decision/Risk Analysis)’s current revenue?

    The current revenue for Dianox (Decision/Risk Analysis) is .

  • How much funding has Dianox (Decision/Risk Analysis) raised over time?

    Dianox (Decision/Risk Analysis) has raised $1.46M.

  • Who are Dianox (Decision/Risk Analysis)’s competitors?

    Totus Medicines, insitro, and Numerion Labs are competitors of Dianox (Decision/Risk Analysis).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process